Vpr-IN transcomplementation experiments

JE Jennifer L Elliott
JE Jenna E Eschbach
PK Pratibha C Koneru
WL Wen Li
MP Maritza Puray-Chavez
DT Dana Townsend
DL Dana Q Lawson
AE Alan N Engelman
MK Mamuka Kvaratskhelia
SK Sebla B Kutluay
request Request a Protocol
ask Ask a question
Favorite

A class I IN mutant virus (HIV-1NL4-3 IND116N) was trans-complemented with class II mutant IN proteins as described previously (Liu et al., 1997). Briefly, HEK293T cells grown in 24-well plates were co-transfected with a derivative of the full-length HIV-1NL4-3 proviral plasmid bearing a class I IN substitution (pNL4-3D116N), VSV-G, and derivatives of the pLR2P-vprIN plasmid bearing class II IN mutations at a ratio of 6:1:3. Two days post-transfection cell-free virions were collected from cell culture supernatants. Integration capability of the trans-complemented class II IN mutants was tested by infecting MT-4 cells and measuring the yield of progeny virions in cell culture supernatants over a 6 d period as described previously (Liu et al., 1997). In brief, MT-4 cells were incubated with virus inoculum in 96 V-bottom well plates for 4 hr at 37°C after which the virus inoculum was washed away and replaced with fresh media. Immediately following removal of the virus inoculum and during the 6 subsequent days, the number of virions present in the culture supernatant was quantified by measuring RT activity using a Q-PCR-based assay (Pizzato et al., 2009).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A